Informed consent must be obtained from all patients prior to beginning therapy. Patients should have the ability to understand and the willingness to sign a written informed consent document.
You may not be if
Patients with histologically documented not (stage Ⅰ/Ⅱ/ⅢA ) non-small cell lung cancer.
After the operation review, patients' result of CTC, CT and tumor markers is incomplete at the same point.
The blood sample isn't collected in predetermined time.
The blood samples appear hemolysis.
The blood sample isn't enough.
Clareo Health | The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring
